Table 2. The relevance of SENP3 and pY705-STAT3 in clinical features.
| Characteristics | Positivity area of SENP3 (%) | Positivity area of p-STAT3 (%) | R-value | P-value |
|---|---|---|---|---|
| Tobacco smoking | ||||
| Yes | 29.81±14.41 | 33.18±14.49 | 0.555 | 0.000 |
| No | 24.15±13.29 | 23.26±14.13 | 0.374 | 0.015 |
| Nodal status | ||||
| N0 | 26.37±14.15 | 28.41±14.97 | 0.529 | 0.000 |
| N1-2 | 32.83±13.74 | 35.88±13.69 | 0.654 | 0.000 |
| Tumor stage | ||||
| T1 | 24.56±13.53 | 27.84.±13.93 | 0.475 | 0.000 |
| T2 | 26.64±11.74 | 27.26±14.40 | 0.480 | 0.000 |
| T3 | 31.41±15.42 | 33.86.±13.23 | 0.725 | 0.000 |
| T4 | 37.66±16.40 | 42.10±16.80 | 0.746 | 0.000 |
| Clinical stage (TNM classification) | ||||
| I | 24.56±13.53 | 27.84±13.93 | 0.475 | 0.000 |
| II | 23.86±9.375 | 25.68±15.09 | 0.407 | 0.010 |
| III | 32.07±15.74 | 33.78.±13.38 | 0.773 | 0.000 |
| IV | 36.64±14.96 | 38.96±15.45 | 0.573 | 0.003 |
Abbreviations: STAT3, signal transducer and activator of transcription 3; TNM, tumor, lymph node, metastasis.